Pituitary & hypothalamus

Impact of GH and IGF-I excess on nervous and vascular retinal structure in newly diagnosed acromegaly patients

PituitaryPublished Prospective case-control study

Authors' conclusion

As acromegaly patients exhibited an impairment either in nervous and in vascular retinal structure at diagnosis, even in the absence of chiasmal compression, SD-OCT and OCTA may represents potential tools to detect retinal damage in these patients.

Study context

Population
Newly diagnosed (naïve) acromegaly patients without chiasmal compression; 8 men, 4 women, mean age 49.1 ± 12.3 years
Participants
12 vs 12
Comparison
Naïve acromegaly patients vs healthy controls
  • Patientsn = 12
  • Controlsn = 12reference
Outcome
Retinal nervous and vascular structure (Spectral Domain Optical Coherence Tomography (SD-OCT), Optical Coherence Tomography Angiography (OCTA))
Follow-up
At diagnosis

Main finding

As reported in the abstract

  • Patients vs Controls: P = 0.001
  • Patients vs Controls: P = 0.007
  • Patients vs Controls: P < 0.001
  • Patients vs Controls: P = 0.009
  • Patients vs Controls: P = 0.03

Observational data: associations, not effects.

Further findings

Predictors of ganglion cell complex (GCC) and retinal nerve fiber layers (RNFL) average (regression, patients)

Adenoma volume: best predictor of GCC
P < 0.001
Diagnostic delay: best predictor of RNFL average
P < 0.001

Vessel density (VD) in radial peripapillary capillary (RPC) by diagnostic delay and fasting glucose (patients)

Lower VD in RPC with diagnostic delay above 8.5 years (median) vs below
P = 0.009
Lower VD in RPC with fasting glucose above 90 mg/dl (median) vs below
P = 0.04

Original publication

Impact of GH and IGF-I excess on nervous and vascular retinal structure in newly diagnosed acromegaly patients. Pituitary. Published 10 October 2025. doi:10.1007/s11102-025-01565-6

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.